We Analyzed Data From the Start of the COVID-19 Pandemic to 2024 – What Did We find?
Gregory Piazza, Director of the Vascular Medicine Section at Brigham and Women’s Hospital, shared on LinkedIn:
“So excited to share the publication in JAHA of this long-term project focused on Adjudicated Cardiovascular Events in Patients with COVID-19, the CORONA-VTE Network Study. While many studies have relied upon large dataset analyses and diagnosis codes to understand the impact of COVID-19, we chose to create a large, unique multicenter registry with adjudicated endpoints providing data from the start of the pandemic to 2024. What did we find? The hazard of cardiovascular events has not diminished, contrary to other reports, AND vaccination is associated with reduced risk. So proud of our research team and collaborators across the CORONA-VTE Network.”
Title: Adjudicated Cardiovascular Events in Patients With COVID‐19: Association With Vaccination Status and Changes over Time
Authors: Behnood Bikdeli, Darsiya Krishnathasan, Antoine Bejjani,…, Gregory Piazza
Stay updated with Hemostasis Today.
-
Apr 6, 2026, 05:34Lena Volland: Scientific Exchange in Bleeding Disorders at the WFH 2026 World Congress
-
Apr 6, 2026, 04:46Ursula Porage Dona: Bringing the Bleeding Disorders Community Together at WFH 2026 with NNHF
-
Apr 6, 2026, 04:17Arun V J: How War Reshaped Blood Transfusion
-
Apr 6, 2026, 03:57Isabella Cieri: How TEG Is Transforming Vascular Surgery Care
-
Apr 5, 2026, 19:00Kausik Ray: Comparing Lipid Management in France vs. Rest of Europe for High Cardiovascular Risk Patients
-
Apr 5, 2026, 18:22Omar Adwan: Systematic Approach to Blood Smear Examination
-
Apr 5, 2026, 18:05Heghine Khachatryan: Rethinking Hemostatic Targets in Pregnancy for von Willebrand Disease
-
Apr 5, 2026, 17:45Matthew Walls: Recognising CAD PRS as a New ‘Risk Enhancing Factor’ in the 2026 ACC/AHA Guidelines
-
Apr 5, 2026, 17:44Philip A. Chan: Occasional Heavy Drinking Leads to 3 Times Higher Liver Fibrosis Risk in MASLD